Adagene Future Growth
Future criteria checks 2/6
Adagene's earnings are forecast to decline at 15.5% per annum while its annual revenue is expected to grow at 41.7% per year. EPS is expected to grow by 3.8% per annum. Return on equity is forecast to be -51.7% in 3 years.
Key information
-15.5%
Earnings growth rate
3.8%
EPS growth rate
Biotechs earnings growth | 24.2% |
Revenue growth rate | 41.7% |
Future return on equity | -51.7% |
Analyst coverage | Low |
Last updated | 24 Jun 2024 |
Recent future growth updates
Recent updates
Adagene Inc. (NASDAQ:ADAG) Surges 26% Yet Its Low P/S Is No Reason For Excitement
Oct 10The Consensus EPS Estimates For Adagene Inc. (NASDAQ:ADAG) Just Fell Dramatically
Oct 05Adagene ADR GAAP EPS of -$0.87 misses by $0.45, revenue of $3.93M misses by $9.82M
Aug 30Micro-cap Adagene surges after hours on $10M share buyback
Jun 29Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 19 | -104 | -100 | -97 | 3 |
12/31/2025 | 9 | -81 | -72 | -69 | 2 |
12/31/2024 | 18 | -45 | -50 | -47 | 1 |
12/31/2023 | 18 | -19 | -29 | -28 | N/A |
9/30/2023 | 20 | -28 | N/A | N/A | N/A |
6/30/2023 | 23 | -36 | N/A | N/A | N/A |
3/31/2023 | 16 | -58 | N/A | N/A | N/A |
12/31/2022 | 9 | -80 | -49 | -49 | N/A |
9/30/2022 | 11 | -82 | N/A | N/A | N/A |
6/30/2022 | 13 | -84 | N/A | N/A | N/A |
3/31/2022 | 11 | -78 | N/A | N/A | N/A |
12/31/2021 | 10 | -73 | -46 | -43 | N/A |
9/30/2021 | 6 | -68 | N/A | N/A | N/A |
6/30/2021 | 2 | -62 | N/A | N/A | N/A |
3/31/2021 | 1 | -52 | N/A | N/A | N/A |
12/31/2020 | 1 | -43 | -29 | -29 | N/A |
9/30/2020 | 1 | -34 | -27 | -26 | N/A |
6/30/2020 | 1 | -28 | -21 | -21 | N/A |
3/31/2020 | 1 | -22 | -20 | -20 | N/A |
12/31/2019 | 0 | -17 | -18 | -18 | N/A |
12/31/2018 | 2 | -14 | -15 | -14 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ADAG is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ADAG is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ADAG is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ADAG's revenue (41.7% per year) is forecast to grow faster than the US market (8.6% per year).
High Growth Revenue: ADAG's revenue (41.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ADAG is forecast to be unprofitable in 3 years.